Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IPGaia
Minato, Tokyo, Japanip-g.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
IPGaia operates a collaborative drug discovery platform that sources early-stage research programs ("drug seeds") from global academic institutions. It develops these into pre-clinical candidates with the goal of licensing them to pharmaceutical companies. No clinical results have been reported as the company focuses on pre-clinical R&D.
- Modalities
- Small moleculeAntibody
- Industry
- Drug Discovery Services
02
Partnerships
Axcelead, Inc.Axcelead Drug Discovery Partners, Inc.PassPort Technologies, Inc.University of California San DiegoIcahn School of Medicine at Mount SinaiTohoku University Hospital
Beyond the preview
Go deeper on IPGaia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IPGaia.